未登录.png)
分享.png)
收藏Diagnostic Performance of Fecal Biomarkers and Their Correlation with Endoscopic Severity in Immune Checkpoint Inhibitor-Related Colitis粪便生物标志物的诊断性能及其与免疫检查点抑制剂相关结肠炎内镜严重程度的相关性
Morikawa, Ryo; Fujii, Toshimitsu; Tamura, Akiko; Kawamoto, Ami; Hibiya, Shuji; Takenaka, Kento; Shimizu, Hiromichi; Kano, Yoshihito; Suenaga, Mitsukuni; Hamamoto, Yasuo; Ohtsuka, Kazuo; Okamoto, Ryuichi 分享 收藏 Feasibility of endoscopic response evaluation after induction chemotherapy for determining treatment strategies in esophageal cancer: a post hoc analysis of the CROC trial内镜评估诱导化疗后食管癌治疗策略可行性的研究：CROC试验的事后分析Katada, Chikatoshi; Yokoyama, Tetsuji; Watanabe, Akinori; Hamamoto, Yasuo; Hosokawa, Ayumu; Kojima, Takashi; Hara, Hiroki; Yoshii, Takako; Fujii, Hirofumi; Yamaguchi, Hironori; Nakajima, Takako Eguchi; Izawa, Naoki; Ando, Takayuki; Nomura, Motoo; Yamashita, Keishi; Kawakami, Shogo; Ishiyama, Hiromichi; Inoue, Yusuke; Sakamoto, Yasutoshi; Ishikawa, Hideki; Muto, Manabu; Tahara, Makoto; Koizumi, Wasaburo 分享 收藏 分享 收藏 Multicenter Retrospective Study of Efficacy of Systemic Therapy in Patients with Neuroendocrine Tumor Grade 3 (JOSC-2001)多中心回顾性研究：系统性疗法在神经内分泌肿瘤3级患者中的疗效（JOSC-2001）Okuyama, Hiroyuki; Shibuki, Taro; Okano, Naohiro; Mizukami, Takuro; Yanagimoto, Hiroaki; Okada, Mao; Kita, Emiri; Kobayashi, Noritoshi; Kobayashi, Satoshi; Furukawa, Takaaki; Asama, Hiroyuki; Tsumura, Hidetaka; Kamata, Ken; Umemoto, Kumiko; Hamamoto, Yasuo; Suzuki, Yuko; Horiguchi, Shigeru; Naganuma, Atsushi; Asagi, Akinori; Tsuji, Kunihiro; Takada, Ryoji; Kawata, Kazuhito; Kojima, Motohiro; Imaoka, Hiroshi; Terashima, Takeshi; Ozaka, Masato; Ueno, Makoto; Ikeda, Masafumi 分享 收藏 分享 收藏 Optimizing Organ-Preservation Strategies Through Chemotherapy-Based Selection in Esophageal Squamous Cell Carcinoma: Results From the CROC Multi-Institutional Phase 2 Clinical TrialKatada, Chikatoshi; Yokoyama, Tetsuji; Watanabe, Akinori; Hara, Hiroki; Yoshii, Takako; Fujii, Hirofumi; Yamaguchi, Hironori; Nakajima, Takako Eguchi; Izawa, Naoki; Ando, Takayuki; Nomura, Motoo; Kojima, Takashi; Yamashita, Keishi; Kawakami, Shogo; Ishiyama, Hiromichi; Inoue, Yusuke; Sakamoto, Yasutoshi; Sasaki, Hiroki; Ishikawa, Hideki; Hosokawa, Ayumu; Hamamoto, Yasuo; Muto, Manabu; Tahara, Makoto; Koizumi, Wasaburo 分享 收藏 Clinical utility of upfront comprehensive genomic profiling for the treatment of advanced pancreatic cancerSo, E.; Hayashi, H.; Shimozaki, K.; Sato, Y.; Horie, S.; Kishimoto, S.; Chida, A.; Saito, Y.; Tsugaru, K.; Hirata, K.; Nishihara, H.; Kanai, T.; Hamamoto, Y. 分享 收藏 Establishing real-world data on actual advanced gastric cancer therapy using CyberOncology: a feasibility studyMachida, N.; Kadowaki, S.; Nishina, T.; Sunakawa, Y.; Maekita, T.; Matsumoto, S.; Nishioka, M.; Goto, T.; Hamamoto, Y.; Yasui, H.; Furuta, M.; Kajiwara, T.; Arai, H.; Kitano, M.; Nagashima, F.; Kawabe, R.; Okada, M.; Muto, M.; Muro, K. 分享 收藏 Definitive chemoradiotherapy with paclitaxel for locally advanced esophageal squamous cell carcinoma in older patients (PARADISE-1): a phase I trialHirata, Kenro; Yoshida, Kayo; Katada, Chikatoshi; Watanabe, Akinori; Tsushima, Takahiro; Yamaguchi, Toshifumi; Yamamoto, Sachiko; Ishikawa, Hideki; Sato, Yasunori; Imamura, Chiyo K.; Tanigawara, Yusuke; Ito, Yoshinori; Kato, Ken; Kitagawa, Yuko; Hamamoto, Yasuo 分享 收藏 Real-world evidence of precision medicine for biliary tract cancerHayashi, Hideyuki; Tanishima, Shigeki; Fujikura, Tomoka; Nakamura, Kohei; Ishikawa, Marin; Kato, Yasutaka; Kawano, Ryutaro; Hirata, Kenro; Hamamoto, Yasuo; Nishihara, Hiroshi 分享 收藏 Retrospective study of second-line FOLFOX versus S1 for advanced biliary tract cancerChida, Akihiko; Hamamoto, Yasuo; So, Eiichiro; Shimizu, Satoko; Kishimoto, Shotaro; Horie, Sara; Saito, Yuki; Shimozaki, Keitaro; Togasaki, Kazuhiro; Tsugaru, Kai; Hirata, Kenro; Hayashi, Hideyuki; Kanai, Takanori 分享 收藏 Comprehensive genomic profiling contributes to the prognosis of patients with advanced pancreatic cancerSo, E.; Hayashi, H.; Shimozaki, K.; Horie, S.; Kishimoto, S.; Chida, A.; Saito, Y.; Tsugaru, K.; Hirata, K.; Nishihara, H.; Kanai, T.; Hamamoto, Y. 分享 收藏 Safety, efficacy, and biomarkers for ONO-4578 plus nivolumab in unresectable advanced or recurrent gastric or gastroesophageal cancerHirano, H.; Kawazoe, A.; Yamaguchi, K.; Hamaguchi, T.; Narita, Y.; Boku, S.; Oshima, T.; Hara, H.; Hamamoto, Y.; Esaki, T.; Ishido, K. 分享 收藏 Mutational spectrum of TP53 gene correlates with nivolumab treatment efficacy in advanced gastric cancer (TP53MUT study)TP53基因的突变谱与晚期胃癌的nivolumab治疗效果相关 (TP53MUT研究)Ando, Koji; Nakamura, Yoshiaki; Kitao, Hiroyuki; Shimokawa, Mototsugu; Kotani, Daisuke; Bando, Hideaki; Nishina, Tomohiro; Yamada, Takanobu; Yuki, Satoshi; Narita, Yukiya; Hara, Hiroki; Ohta, Takashi; Esaki, Taito; Hamamoto, Yasuo; Kato, Ken; Yamamoto, Yoshiyuki; Minashi, Keiko; Ohtsubo, Koushiro; Izawa, Naoki; Kawakami, Hisato; Kato, Takeshi; Satoh, Taroh; Okano, Naohiro; Tsuji, Akihito; Yamazaki, Kentaro; Yoshino, Takayuki; Maehara, Yoshihiko; Oki, Eiji 分享 收藏 Real-world management and outcomes of older patients with locally advanced esophageal squamous cell carcinoma: a multicenter retrospective studySaito, Yuki; Hamamoto, Yasuo; Hirata, Kenro; Yamasaki, Makoto; Watanabe, Masaya; Abe, Tetsuya; Tsubosa, Yasuhiro; Hamai, Yoichi; Murakami, Kentaro; Bamba, Takeo; Yoshii, Takako; Tsuda, Masahiro; Watanabe, Masayuki; Ueno, Masaki; Kitagawa, Yuko 分享 收藏 WJOG13219G: The Efficacy and Safety of FOLFOXIRI or Doublet plus Anti-VEGF Therapy in Previously Untreated BRAFV600E Mutant Metastatic Colorectal Cancer: A Multi-Institutional Registry-Based Study (BRACELET Study)WJOG13219G: FOLFOXIRI或Doublet联合抗VEGF治疗先前未治疗的BRAFV600E突变转移性结直肠癌的疗效和安全性: 一项基于多机构注册研究 (手镯研究)Shimozaki, Keitaro; Hirata, Kenro; Sato, Taro; Nakamura, Maho; Kato, Kyoko; Hirano, Hidekazu; Kumekawa, Yosuke; Hino, Kaori; Kawakami, Kentaro; Kito, Yosuke; Matsumoto, Toshihiko; Kawakami, Takeshi; Komoda, Masato; Nagashima, Kengo; Sato, Yasunori; Yamazaki, Kentaro; Hironaka, Shuichi; Takaishi, Hiromasa; Hamamoro, Yasuo; Muro, Kei 分享 收藏 Three-Year Follow-Up and Response-Survival Relationship of Nivolumab in Previously Treated Patients with Advanced Esophageal Squamous Cell Carcinoma (ATTRACTION-3)Nivolumab在先前治疗的晚期食管鳞状细胞癌患者中的三年随访和反应-生存关系 (吸引力-3)Okada, Morihito; Kato, Ken; Cho, Byoung Chul; Takahashi, Masanobu; Lin, Chen-Yuan; Chin, Keisho; Kadowaki, Shigenori; Ahn, Myung-Ju; Hamamoto, Yasuo; Doki, Yuichiro; Yen, Chueh-Chuan; Kubota, Yutaro; Kim, Sung-Bae; Hsu, Chih-Hung; Holtved, Eva; Xynos, Ioannis; Matsumura, Yasuhiro; Takazawa, Akira; Kitagawa, Yuko 分享 收藏 Concordance analysis of microsatellite instability status between polymerase chain reaction based testing and next generation sequencing for solid tumorsShimozaki, Keitaro; Hayashi, Hideyuki; Tanishima, Shigeki; Horie, Sara; Chida, Akihiko; Tsugaru, Kai; Togasaki, Kazuhiro; Kawasaki, Kenta; Aimono, Eriko; Hirata, Kenro; Nishihara, Hiroshi; Kanai, Takanori; Hamamoto, Yasuo 分享 收藏 Exploration of predictors of benefit from nivolumab monotherapy for patients with pretreated advanced gastric and gastroesophageal junction cancer: post hoc subanalysis from the ATTRACTION-2 studynivolumab单药治疗预处理的晚期胃癌和胃食管交界癌患者获益预测因素的探索: 来自吸引力-2研究的事后子分析Kang, Yoon-Koo; Morita, Satoshi; Satoh, Taroh; Ryu, Min-Hee; Chao, Yee; Kato, Ken; Chung, Hyun Cheol; Chen, Jen-Shi; Muro, Kei; Kang, Won Ki; Yeh, Kun-Huei; Yoshikawa, Takaki; Oh, Sang Cheul; Bai, Li-Yuan; Tamura, Takao; Lee, Keun-Wook; Hamamoto, Yasuo; Kim, Jong Gwang; Chin, Keisho; Oh, Do-Youn; Minashi, Keiko; Cho, Jae Yong; Tsuda, Masahiro; Sameshima, Hiroki; Chen, Li-Tzong; Boku, Narikazu 分享 收藏 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
